Vitura Health (ASX:VIT) Debt-to-Equity : 0.44 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Vitura Health Debt-to-Equity?

Vitura Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$5.0 Mil. Vitura Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$13.0 Mil. Vitura Health's Total Stockholders Equity for the quarter that ended in Dec. 2024 was A$41.0 Mil. Vitura Health's debt to equity for the quarter that ended in Dec. 2024 was 0.44.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Vitura Health's Debt-to-Equity or its related term are showing as below:

ASX:VIT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.2 Max: 0.44
Current: 0.44

During the past 6 years, the highest Debt-to-Equity Ratio of Vitura Health was 0.44. The lowest was 0.04. And the median was 0.20.

ASX:VIT's Debt-to-Equity is ranked worse than
64.13% of 814 companies
in the Drug Manufacturers industry
Industry Median: 0.27 vs ASX:VIT: 0.44

Vitura Health Debt-to-Equity Historical Data

The historical data trend for Vitura Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitura Health Debt-to-Equity Chart

Vitura Health Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Debt-to-Equity

Get a 7-Day Free Trial

0.30

0.25

0.19

0.04

0.28

Vitura Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial							0.16	0.04	0.31	0.28	0.44

Competitive Comparison of Vitura Health's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitura Health's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vitura Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Vitura Health's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Vitura Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Vitura Health's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.726	+	9.295)	/	38.784
	=	0.28

Vitura Health's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.964	+	12.976)	/	40.959
	=	0.44

Vitura Health (ASX:VIT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Vitura Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Vitura Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitura Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vitura Health Ltd (ASX:VIT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

299 Toorak Road, Suite 8, Level 3, South Yarra, VIC, AUS, 3141

Website

https://www.vitura.com.au

Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.

Vitura Health Headlines

No Headlines